Axitinib sensitization of high Single Dose Radiotherapy Academic Article uri icon

Overview

MeSH Major

  • Imidazoles
  • Indazoles
  • Melanoma, Experimental
  • Radiation-Sensitizing Agents
  • Sarcoma, Experimental

abstract

  • Axitinib radiosensitizes tumor endothelial cells and enhances tumor cure with SDRT, which may permit dose de-escalation and significantly expand the range of clinical indications for SDRT.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4278650

Digital Object Identifier (DOI)

  • 10.1016/j.radonc.2014.02.010

PubMed ID

  • 24794795

Additional Document Info

start page

  • 88

end page

  • 93

volume

  • 111

number

  • 1